Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 ATTAIN-1 trial, evaluating ...

Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market ...

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...

As other pharmas drop next-gen obesity assets, Eli Lilly’s experimental oral GLP-1 has prompted weight loss up to an average ...

An experimental weight-loss pill developed by Eli Lilly helped people lose up to about 12% of their body weight after more ...

Weapons, directed by Zach Cregger, is a psychological horror-thriller starring Josh Brolin, Julia Garner, and Austin Abrams.

Fortinet, AppLovin, Airbnb, Duolingo and more stock were making big moves Thursday after the companies reported quarterly ...

According to Chamelin’s grant application, the church plans to spend $1,500 to buy the livestock, $375 to butcher, process ...

Novo Nordisk faces slowing revenue growth, weak Q2 2025 results, and a more conservative outlook. Read why I rate NVO stock a ...

U.S. stock futures rose on Thursday after ending higher on Wednesday. Futures of major benchmark indices were up.

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...

O'Reilly Automotive Inc. is suing the three major pharmacy benefit managers in the U.S., as well as the three major insulin manufacturers.